Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A research team, led by the National Physical Laboratory (NPL), has carried out studies into how protein fragments found in our bodies destroy harmful bacteria - potentially moving us a step closer to a new generation of antibiotic treatment that is less prone to bacterial resistance.
The protein fragments, known as antimicrobial peptides, have fought bacteria in the human body for thousands of years by identifying and disrupting the structure of the bacterial membrane. But little is still known about the precise mechanisms they use to carry out this process. The NPL-led team conducted two separate studies to better understand the process and help assess the feasibility of using human antimicrobial peptides as the basis of new treatments.
The first study used de novo protein design and nanoscale imaging techniques, Atomic Force Microscopy and high resolution Mass Spectrometry, together with computer simulations. This combination, never used before for this application, allowed the scientists to study how the peptides destroy the bacteria on a molecular level.
The research, reported in PNAS, revealed that the peptides form nanoscale pores in the bacterial membranes, which subsequently expand until the membrane completely disintegrates. In targeting the membrane, a heterogeneous structure composed predominantly of proteins and lipids, it is thought that the peptides reduce the likelihood that bacteria will develop resistance. This is because many genes would need to mutate simultaneously in order to do so - a very unlikely scenario.
However, before they are considered for medical use, it is important that scientists understand the likelihood of bacteria becoming resistant to the peptides. A second NPL-led study looked to do just that, using a combination of measurements, imaging and molecular dynamics simulations. It explored whether and how bacteria could develop resistance to these antibiotic peptides as they have to conventional antibiotics like methicillin.
The findings, reported in the Journal of Biological Chemistry, suggest that antagonistic peptide chains secreted by bacterial cells or expressed on their surfaces may cause efficient anti-antimicrobial responses, meaning that bacteria could potentially thrive in the presence of the peptides. This discovery may give scientists a better understanding of bacterial resistance and help them choose the right approach when developing the peptides for medical use.
Dr. Max Ryadnov, who leads NPL's scientific research in Biotechnology, said: "It is widely known that these antimicrobial peptides are very efficient at destroying bacteria, but previous measurement techniques only let us see to a detail of five nanometres. The unique combination of technologies used in this research allowed us to see the process at larger length scales and in finer detail. The implications of these research efforts could be considerable - potentially paving the way for an alternative to the current, increasingly inefficient, antibiotic treatments, but also helping us understand the potential vulnerabilities of therapeutics based on these peptides."
The research was led by NPL and featured scientists from the London Centre for Nanotechnology, UCL, University of Edinburgh, University of Bristol, University of Oxford, Freie Universität Berlin and IBM.
 Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers, Published online before print May 13, 2013, doi: 10.1073/pnas.1222824110 PNAS
 Anti-antimicrobial Peptides FOLDING-MEDIATED HOST DEFENSE ANTAGONISTS*, The Journal of Biological Chemistry, First Published on June 4, 2013, doi: 10.1074/jbc.M113.459560
National Physical Laboratory
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Infectious Diseases / Bacteria / Viruses category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Laboratory, National Physical. "NPL-led studies explore bacteria-destroying proteins for more efficient antibiotics." Medical News Today. MediLexicon, Intl., 25 Sep. 2013. Web.
11 Dec. 2013. <http://www.medicalnewstoday.com/releases/266540>
Laboratory, N. (2013, September 25). "NPL-led studies explore bacteria-destroying proteins for more efficient antibiotics." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266540.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.